Last updated on September 2018

Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome


Brief description of study

The purpose of the study is to evaluate whether LIK066 can be developed for the treatment of polycystic ovary syndrome (PCOS) in overweight and obese women.

Clinical Study Identifier: NCT03152591

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Baton Rouge, LA United States

Novartis Pharmaceuticals

Novartis Investigative Site
Springfield, MO United States

Novartis Pharmaceuticals

Novartis Investigative Site
Philadelphia, PA United States

Novartis Pharmaceuticals

Novartis Investigative Site
Berlin, Germany

Novartis Pharmaceuticals

Novartis Investigative Site
Essen, Germany

Novartis Pharmaceuticals

Novartis Investigative Site
Freiburg, Germany

Novartis Pharmaceuticals

Novartis Investigative Site
Muenchen, Germany